arrow_back Back to App

July 2025: National Sarcoma Awareness Month in the US

The U.S. Senate has supported designating July 2025 as National Sarcoma Awareness Month. This initiative aims to increase public knowledge about this rare cancer and encourage citizens to seek early diagnosis and treatment, potentially improving health outcomes. The action seeks to highlight an issue affecting thousands of individuals annually.
Key points
Raising public awareness about sarcomas, rare cancers of bones and connective tissues.
Encouraging early detection and treatment of sarcomas, which can improve patient prognoses.
Highlighting the scale of the problem: approximately 17,000 new diagnoses and 7,600 deaths annually in the U.S.
article Official text account_balance Process page
Adopted
Citizen Poll
No votes cast
Additional Information
Print number: 119_SRES_299
Sponsor: Sen. Johnson, Ron [R-WI]
Process start date: 2025-06-24
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

A resolution expressing support for the designation of July 2025 as "National Sarcoma Awareness Month".

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 119_SRES_299.

Which chamber initiated this legislation?

This legislation was initiated in the Senate.

When did the legislative process begin?

The process officially started on 2025-06-24.

What are the main provisions?

Key points include:

  • Raising public awareness about sarcomas, rare cancers of bones and connective tissues.
  • Encouraging early detection and treatment of sarcomas, which can improve patient prognoses.
  • Highlighting the scale of the problem: approximately 17,000 new diagnoses and 7,600 deaths annually in the U.S.
What is the specific legal status?

The current status is Adopted.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Sen. Johnson, Ron [R-WI].

What is the latest detailed status?

The latest detailed status is: Submitted in the Senate, considered, and agreed to without amendment and with a preamble by Unanimous Consent. (consideration: CR S3520; text: CR S3518)

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-23.

CATEGORIES

Health